Hartkopp A, et al. Survival and cause of death after traumatic spinal cord injury. A long-term epidemiological survey from Denmark. Spinal Cord. 1997;35(2):76–85.

Article  CAS  PubMed  Google Scholar 

Brandes SB, et al. Renal cell carcinoma in patients with prior spinal cord injury. J Spinal Cord Med. 2001;24(4):251–6.

Article  CAS  PubMed  Google Scholar 

• Ismail S, et al. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: a systematic review. Neurourol Urodyn. 2018;37(4):1386–95. (Systematic review on prevalence and mortality of bladder cancer in NGB population.)

Article  PubMed  Google Scholar 

Nahm LS, et al. Bladder cancer mortality after spinal cord injury over 4 decades. J Urol. 2015;193(6):1923–8.

Article  PubMed  Google Scholar 

Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.

Article  PubMed  Google Scholar 

•• Liu B, Welk B. Urological malignancies in neurogenic patients. Curr Opin Urol. 2020;30(4):501–6. (Review article, overview of urologic malignancies in patients with NGB, mostly focused on prostate and bladder cancer. The review showed a lower incidence of bladder cancer in the NLUTD population than previously found.)

Article  CAS  PubMed  Google Scholar 

Welk B, et al. Bladder cancer in individuals with spinal cord injuries. Spinal Cord. 2013;51(7):516–21.

Article  CAS  PubMed  Google Scholar 

• Prattley S, New F, Davies M. Malignancies of suprapubic catheter (SPC) tracts in spinal cord injury patients: a case series and review of literature. Spinal Cord Ser Cases. 2019;5:34. https://doi.org/10.1038/s41394-019-0177-9. (Authors presented the first case series of malignancy of the SPC tract in SCI patients.)

•• Bothig R, et al. Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre. Int Urol Nephrol. 2017;49(6):983–94. (Single-centre retrospective evaluation of patient data with spinal cord injuries and proven urinary bladder cancer and summary of the literature. The authors found that younger age at onset and the frequency of invasive tumours at diagnosis indicate that spinal cord injury influences bladder cancer risk and prognosis.)

Article  PubMed  Google Scholar 

Gui-Zhong L, Li-Bo M. Bladder cancer in individuals with spinal cord injuries: a meta-analysis. Spinal Cord. 2017;55(4):341–5.

Article  CAS  PubMed  Google Scholar 

Rove KO, et al. Systematic review of bladder cancer outcomes in patients with spina bifida. J Pediatr Urol. 2017;13(5):456 e1-456 e9.

Article  PubMed  Google Scholar 

De Ridder D, et al. Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide. J Urol. 1998;159(6):1881–4.

Article  PubMed  Google Scholar 

Lebrun C, et al. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis. Mult Scler. 2008;14(3):399–405.

Article  PubMed  Google Scholar 

Marrie RA, et al. A systematic review of the incidence and prevalence of cancer in multiple sclerosis. Mult Scler. 2015;21(3):294–304.

Article  PubMed  PubMed Central  Google Scholar 

• Marrie RA, et al. Cancer incidence and mortality rates in multiple sclerosis: a matched cohort study. Neurology. 2021;96(4):e501–12. (The authors found that the incidence of breast and colorectal cancers does not differ between persons with and without MS; however, the incidence of bladder cancer is increased. Overview of bladder cancer incidence and mortality among patients with Multiple Sclerosis.)

Article  CAS  PubMed  Google Scholar 

Grytten N, et al. Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study. Mult Scler Relat Disord. 2021;55:103209.

Article  CAS  PubMed  Google Scholar 

Ho CH, et al. Chronic indwelling urinary catheter increase the risk of bladder cancer, even in patients without spinal cord injury. Medicine (Baltimore). 2015;94(43):e1736.

Article  PubMed  Google Scholar 

Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological followup after spinal cord injury. J Urol. 2012;187(2):391–7.

Article  PubMed  Google Scholar 

Taweel WA, Seyam R. Neurogenic bladder in spinal cord injury patients. Res Rep Urol. 2015;7:85–99.

PubMed  PubMed Central  Google Scholar 

Stonehill WH, et al. Risk factors for bladder tumors in spinal cord injury patients. J Urol. 1996;155(4):1248–50.

Article  CAS  PubMed  Google Scholar 

Pannek J. Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy? Urology. 2002;59(2):240–4.

Article  PubMed  Google Scholar 

Biardeau X, et al. Risk of malignancy after augmentation cystoplasty: a systematic review. Neurourol Urodyn. 2016;35(6):675–82.

Article  PubMed  Google Scholar 

Hoen L, et al. Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: a systematic review. Neurourol Urodyn. 2017;36(7):1685–702.

Article  PubMed  Google Scholar 

Groah SL, et al. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil. 2002;83(3):346–51.

Article  PubMed  Google Scholar 

Esrig D, McEvoy K, Bennett CJ. Bladder cancer in the spinal cord-injured patient with long-term catheterization: a casual relationship? Semin Urol. 1992;10(2):102–8.

CAS  PubMed  Google Scholar 

Hamid R, et al. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury. World J Urol. 2018;36(10):1517–27.

Article  PubMed  Google Scholar 

•• Bothig R, et al. Traumatic spinal cord injury confers bladder cancer risk to patients managed without permanent urinary catheterization: lessons from a comparison of clinical data with the national database. World J Urol. 2020;38(11):2827–34. (Single-centre retrospective evaluation of consecutive in- and out-patient data with spinal cord injury, focusing on bladder cancer risks in the neurogenic bladder population. The author found that in patients with SCI bladder management even without permanent catheterization represents a considerable risk for the development of bladder tumors.)

Article  PubMed  Google Scholar 

Ginsberg DA, et al. The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: treatment and follow-up. J Urol. 2021;206(5):1106–13.

Article  PubMed  Google Scholar 

Ginsberg DA, et al. The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation. J Urol. 2021;206(5):1097–105.

Article  PubMed  Google Scholar 

El Masri y WS, et al. To cystoscope or not to cystoscope patients with traumatic spinal cord injuries managed with indwelling urethral or suprapubic catheters? That is the question! Spinal Cord. 2014;52(1):49–53.

Article  PubMed  Google Scholar 

Hamid R, et al. Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: is it valid? J Urol. 2003;170(2 Pt 1):425–7.

Article  CAS  PubMed  Google Scholar 

Hamid R, et al. Routine surveillance cystoscopy for patients with augmentation and substitution cystoplasty for benign urological conditions: is it necessary? BJU Int. 2009;104(3):392–5.

Article  PubMed  Google Scholar 

Fitzpatrick R, Baverstock R. Muscle invasive bladder cancer presenting as recurrent autonomic dysreflexia - a wolf in wolf’s clothing. J Spinal Cord Med. 2020;43(4):540–3.

Article  PubMed  Google Scholar 

Davis M. When guidelines conflict: patient safety, quality of life, and CAUTI reduction in patients with spinal cord injury. Spinal Cord Ser Cases. 2019;5:56.

Article  PubMed  PubMed Central  Google Scholar 

Lewis J, et al. A framework for transitioning patients from pediatric to adult health settings for patients with neurogenic bladder. Neurourol Urodyn. 2017;36(4):973–8.

Article  PubMed  Google Scholar 

Flaig TW, et al. NCCN guidelines(R) insights: bladder cancer, version 2.2022. J Natl Compr Canc Netw. 2022;20(8):866–78.

Article  PubMed  Google Scholar 

Necchi A, et al. Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies. Eur Urol. 2020;77(4):439–46.

Article  CAS  PubMed  Google Scholar 

Song Y, Xu T. Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder. World J Urol. 2023;41(6):1697–8.

Article  PubMed  Google Scholar 

Delnay KM, et al. Bladder histological changes associated with chronic indwelling urinary catheter. J Urol. 1999;161(4):1106–8 (discussion 1108-9).

Article  CAS  PubMed  Google Scholar 

• Sampogna G, et al. Experience of a tertiary referral center in managing bladder cancer in conjunction with neurogenic bladder. Spinal Cord Ser Cases. 2020;6(1):61. (Single-center retrospective analysis with pre, intra and post operative data for NB with BCa. The authors found that BCa in individuals with NB is associated with a diagnosis at an advanced stage and a high rate of surgical complications.)

Article  PubMed  PubMed Central  Google Scholar 

McMichan JC, Michel L, Westbrook PR. Pulmonary dysfunction following traumatic quadriplegia. Recognition, prevention, and treatment. JAMA. 1980;243(6):528–31.

Article  CAS  PubMed